Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

James Miller

Concepts (326)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Lung Neoplasms
44
2020
2201
2.880
Why?
Smoking
20
2019
1392
1.340
Why?
Bronchi
13
2018
243
1.270
Why?
Carcinoma in Situ
5
2019
43
1.150
Why?
Carcinoma, Squamous Cell
10
2018
577
0.810
Why?
Carcinogens
4
2012
105
0.800
Why?
Chemoprevention
3
2019
88
0.760
Why?
Vascular Endothelial Growth Factor Receptor-2
2
2012
86
0.750
Why?
Lung
16
2020
3595
0.660
Why?
Carcinoma, Small Cell
7
2008
158
0.520
Why?
Bronchopulmonary Dysplasia
2
2019
330
0.510
Why?
Urethane
3
2012
41
0.500
Why?
Bronchoscopy
9
2019
244
0.490
Why?
Sputum
8
2019
285
0.490
Why?
Pulmonary Alveoli
4
2012
374
0.480
Why?
Iloprost
2
2012
46
0.480
Why?
Hyperplasia
7
2011
165
0.480
Why?
Precancerous Conditions
7
2020
156
0.460
Why?
Neprilysin
3
1998
47
0.440
Why?
Biomarkers, Tumor
7
2015
1045
0.430
Why?
Piperidines
2
2012
162
0.420
Why?
Antineoplastic Agents
4
2013
1879
0.410
Why?
Quinazolines
2
2012
240
0.410
Why?
Biopsy
11
2019
1046
0.400
Why?
DNA Copy Number Variations
1
2011
156
0.360
Why?
Genetic Markers
1
2011
323
0.360
Why?
Bombesin
5
1998
12
0.360
Why?
Amidohydrolases
3
1998
28
0.340
Why?
Carcinoma, Non-Small-Cell Lung
7
2013
963
0.340
Why?
Neurosecretory Systems
4
2004
32
0.330
Why?
Mass Screening
3
2008
1012
0.330
Why?
Isotretinoin
1
2009
22
0.330
Why?
Ki-67 Antigen
3
2015
104
0.330
Why?
Tocopherols
1
2009
22
0.330
Why?
Vasodilator Agents
1
2011
307
0.330
Why?
ErbB Receptors
1
2012
555
0.320
Why?
Membrane Proteins
2
2008
1019
0.310
Why?
Pulmonary Disease, Chronic Obstructive
4
2018
928
0.300
Why?
Neovascularization, Pathologic
6
2015
281
0.300
Why?
Respiratory Mucosa
2
2008
251
0.280
Why?
Adenocarcinoma
6
2012
795
0.270
Why?
Hypoxia
1
2012
958
0.260
Why?
Middle Aged
28
2019
26827
0.240
Why?
Aged
25
2019
19119
0.240
Why?
Chromosomes, Human, Pair 3
4
2000
49
0.230
Why?
Chromosome Aberrations
4
2013
135
0.220
Why?
Carcinoma, Bronchogenic
2
2002
17
0.220
Why?
Humans
53
2020
115042
0.210
Why?
Female
33
2019
59613
0.210
Why?
Tomography, Spiral Computed
1
2002
24
0.210
Why?
Sensitivity and Specificity
10
2010
1715
0.200
Why?
Double-Blind Method
2
2019
1664
0.190
Why?
Smokers
2
2019
129
0.190
Why?
Lung Diseases
5
2015
703
0.190
Why?
Male
30
2019
55731
0.190
Why?
Small Cell Lung Carcinoma
2
2012
77
0.190
Why?
Placebos
2
2019
198
0.190
Why?
Tomography, X-Ray Computed
2
2020
2341
0.190
Why?
Tumor Cells, Cultured
6
1998
851
0.170
Why?
Neuropeptides
4
1998
65
0.170
Why?
Radiographic Image Interpretation, Computer-Assisted
1
2020
102
0.170
Why?
Remission Induction
1
2019
233
0.160
Why?
Peptides
3
1996
849
0.160
Why?
In Situ Hybridization, Fluorescence
6
2010
310
0.150
Why?
Blotting, Western
4
2012
1149
0.150
Why?
Genes, p53
1
1997
61
0.150
Why?
Lung Diseases, Obstructive
1
1997
40
0.150
Why?
Antibodies, Monoclonal
3
2010
1268
0.150
Why?
Proteomics
2
2015
844
0.140
Why?
Immunohistochemistry
8
2015
1634
0.140
Why?
Point Mutation
1
1997
217
0.140
Why?
Mice
10
2012
14927
0.130
Why?
Animals
13
2013
31867
0.130
Why?
Radiation Injuries, Experimental
1
1996
25
0.130
Why?
Bradykinin
1
1996
43
0.130
Why?
Endopeptidases
1
1996
72
0.130
Why?
Chromosomal Instability
2
2013
18
0.130
Why?
Smoking Cessation
1
2019
376
0.130
Why?
Risk Factors
5
2019
8642
0.120
Why?
Hyperoxia
1
1996
99
0.120
Why?
Multiple Pulmonary Nodules
1
2015
26
0.120
Why?
Aged, 80 and over
8
2015
6357
0.120
Why?
Gene Expression
3
1998
1423
0.120
Why?
Mice, Transgenic
5
2009
1955
0.120
Why?
Antigens
1
1996
318
0.120
Why?
Methylcholanthrene
2
2012
18
0.120
Why?
Mutation
4
2000
3350
0.120
Why?
Butylated Hydroxytoluene
2
2012
32
0.110
Why?
Algorithms
3
2020
1488
0.110
Why?
Stem Cells
1
2018
546
0.110
Why?
Microarray Analysis
1
2013
119
0.110
Why?
Epithelium
4
2018
297
0.110
Why?
Intramolecular Oxidoreductases
2
2004
57
0.110
Why?
Biological Products
1
1996
171
0.110
Why?
Epithelial Cells
3
2007
956
0.110
Why?
Risk
5
2012
815
0.110
Why?
Carcinoma, Large Cell
1
2012
14
0.110
Why?
Cytochrome P-450 Enzyme System
2
2004
108
0.110
Why?
Case-Control Studies
8
2012
3015
0.100
Why?
Bronchoalveolar Lavage Fluid
3
2002
590
0.100
Why?
Receptors, Bombesin
1
2012
2
0.100
Why?
Volatile Organic Compounds
1
2012
45
0.100
Why?
Immunoenzyme Techniques
1
2012
192
0.100
Why?
Cell Division
4
2000
758
0.100
Why?
Veterans
1
2002
1238
0.100
Why?
Sleep Apnea Syndromes
1
2012
74
0.100
Why?
Dose-Response Relationship, Drug
2
2010
1857
0.100
Why?
Proto-Oncogene Proteins c-myc
1
2012
115
0.100
Why?
Chromosomes, Human, Pair 15
1
2011
53
0.090
Why?
Eosinophilic Granuloma
1
1990
3
0.090
Why?
Epithelial-Mesenchymal Transition
1
2012
167
0.090
Why?
Adult
16
2018
30656
0.090
Why?
Basic Helix-Loop-Helix Transcription Factors
1
2012
225
0.090
Why?
Disease Progression
5
2018
2389
0.090
Why?
Antioxidants
2
2012
530
0.090
Why?
Calcium
1
1996
1104
0.090
Why?
Genome-Wide Association Study
2
2013
1203
0.090
Why?
Proteins
1
1996
915
0.090
Why?
Cell Line
5
2013
2645
0.090
Why?
Predictive Value of Tests
4
2009
1812
0.090
Why?
Plants, Toxic
1
1989
23
0.090
Why?
Cell Proliferation
2
2018
2191
0.080
Why?
Somatomedins
1
2009
29
0.080
Why?
Intracellular Signaling Peptides and Proteins
2
2011
386
0.080
Why?
Chromosome Deletion
1
1989
96
0.080
Why?
Bronchial Neoplasms
1
2009
14
0.080
Why?
Neoplasms, Glandular and Epithelial
1
2009
34
0.080
Why?
Neoplasm Invasiveness
4
2015
442
0.080
Why?
GPI-Linked Proteins
1
2008
54
0.080
Why?
Respiratory System
1
1989
138
0.080
Why?
Fluorescence
3
2009
148
0.080
Why?
Airway Obstruction
3
2009
168
0.070
Why?
Inflammation
1
2018
2485
0.070
Why?
Polymorphism, Genetic
1
2011
617
0.070
Why?
Alkaline Phosphatase
1
2008
143
0.070
Why?
Spectral Karyotyping
1
2007
5
0.070
Why?
Molecular Targeted Therapy
1
2010
347
0.070
Why?
Fibroblasts
3
1998
839
0.070
Why?
Isoenzymes
1
2008
286
0.070
Why?
Proto-Oncogene Proteins p21(ras)
1
2008
228
0.070
Why?
Cell Transformation, Neoplastic
1
2009
311
0.070
Why?
Pulmonary Surfactants
2
1999
101
0.070
Why?
Early Detection of Cancer
1
2010
339
0.070
Why?
Exons
2
1998
301
0.070
Why?
Molecular Sequence Data
5
1998
2796
0.070
Why?
Follow-Up Studies
2
2015
4420
0.070
Why?
MicroRNAs
1
2012
603
0.070
Why?
Polymorphism, Single Nucleotide
1
2013
1901
0.070
Why?
Biomarkers
3
2010
3419
0.070
Why?
ROC Curve
3
2015
447
0.070
Why?
Enzyme-Linked Immunosorbent Assay
3
2005
797
0.060
Why?
Adaptor Proteins, Signal Transducing
1
2008
370
0.060
Why?
Recombinant Proteins
3
1998
1237
0.060
Why?
RNA, Messenger
3
1998
2563
0.060
Why?
Polymerase Chain Reaction
3
1998
999
0.060
Why?
Protein Kinase Inhibitors
1
2010
786
0.060
Why?
Cytokines
1
2012
1843
0.060
Why?
Growth Hormone-Releasing Hormone
1
2004
27
0.060
Why?
Acromegaly
1
2004
12
0.060
Why?
Rats
4
2004
4973
0.060
Why?
Neoplasm Recurrence, Local
1
2009
856
0.060
Why?
Adrenocorticotropic Hormone
1
2004
128
0.060
Why?
Cross-Sectional Studies
2
2018
4411
0.050
Why?
Smoke
1
2004
127
0.050
Why?
Base Sequence
3
1998
2119
0.050
Why?
Solitary Pulmonary Nodule
1
2002
25
0.050
Why?
Metaplasia
2
2018
54
0.050
Why?
Sex Factors
1
2007
1721
0.050
Why?
Vascular Endothelial Growth Factor A
1
2005
499
0.050
Why?
Pulmonary Fibrosis
2
1998
323
0.050
Why?
Radiation Dosage
1
2002
138
0.050
Why?
Hospitals, Veterans
1
2002
244
0.050
Why?
Reproducibility of Results
1
2008
2799
0.050
Why?
Cohort Studies
4
2015
4904
0.040
Why?
Gene Expression Regulation
1
1989
2329
0.040
Why?
Feasibility Studies
1
2002
746
0.040
Why?
Amino Acid Sequence
3
1994
1990
0.040
Why?
Signal Transduction
3
1998
4525
0.040
Why?
Gastrin-Releasing Peptide
2
1996
6
0.040
Why?
Light
1
2001
335
0.040
Why?
Autocrine Communication
1
1998
42
0.040
Why?
gamma Catenin
1
2018
17
0.040
Why?
Desmoglein 3
1
2018
17
0.040
Why?
Loss of Heterozygosity
2
2013
41
0.040
Why?
Gene Expression Profiling
1
2005
1523
0.040
Why?
Up-Regulation
2
2005
812
0.040
Why?
DNA Primers
2
1998
514
0.040
Why?
Paracrine Communication
1
1998
56
0.040
Why?
Bronchial Diseases
1
2018
38
0.040
Why?
Neoplasm Transplantation
1
1998
230
0.040
Why?
United States
2
2011
12226
0.040
Why?
Cell Cycle Checkpoints
1
2018
84
0.040
Why?
Time
1
2018
71
0.040
Why?
Vascular Cell Adhesion Molecule-1
1
1998
35
0.040
Why?
Telangiectasia, Hereditary Hemorrhagic
1
1998
10
0.040
Why?
Polymorphism, Single-Stranded Conformational
1
1997
26
0.040
Why?
Genes, Tumor Suppressor
1
1998
78
0.040
Why?
Likelihood Functions
1
1998
126
0.040
Why?
Neoplasm Staging
2
2012
1169
0.040
Why?
Alveolitis, Extrinsic Allergic
1
1998
92
0.040
Why?
Polymorphism, Restriction Fragment Length
1
1997
65
0.040
Why?
DNA, Complementary
1
1998
257
0.040
Why?
Treatment Outcome
1
2011
9122
0.040
Why?
Gene Expression Regulation, Enzymologic
1
1998
271
0.040
Why?
Codon
1
1997
86
0.040
Why?
Introns
1
1998
227
0.040
Why?
Membrane Glycoproteins
1
1999
429
0.040
Why?
Mice, Nude
1
1998
631
0.040
Why?
Incidence
3
2010
2318
0.040
Why?
Machine Learning
1
2020
318
0.030
Why?
Immunoassay
2
1998
95
0.030
Why?
Enzyme Activation
1
1998
791
0.030
Why?
RNA, Neoplasm
1
1996
80
0.030
Why?
Image Processing, Computer-Assisted
1
2020
698
0.030
Why?
Mesothelioma
1
1996
31
0.030
Why?
Glycopeptides
1
1996
43
0.030
Why?
Antigens, CD
2
1998
441
0.030
Why?
Databases, Factual
1
2020
1132
0.030
Why?
Sequence Analysis, DNA
1
1998
728
0.030
Why?
Proto-Oncogene Proteins
1
2018
609
0.030
Why?
Cell Cycle Proteins
1
2018
551
0.030
Why?
Myelin Sheath
1
1996
144
0.030
Why?
Prospective Studies
3
2012
6232
0.030
Why?
Receptors, Peptide
1
1994
18
0.030
Why?
Rh-Hr Blood-Group System
1
1994
11
0.030
Why?
Liver Neoplasms
1
1998
516
0.030
Why?
Neoplasm Metastasis
1
1996
524
0.030
Why?
Erythrocyte Membrane
1
1994
50
0.030
Why?
Blotting, Southern
1
1993
68
0.030
Why?
Blotting, Northern
1
1993
193
0.030
Why?
Endoscopy
1
2015
246
0.030
Why?
Cells, Cultured
2
2007
3896
0.030
Why?
Colorado
1
2002
4089
0.030
Why?
Gene Expression Regulation, Neoplastic
1
2018
1144
0.030
Why?
DNA, Neoplasm
1
1993
157
0.030
Why?
Solid Phase Microextraction
1
2012
6
0.030
Why?
Enzyme Inhibitors
1
1996
752
0.030
Why?
Dinoprostone
2
2004
185
0.030
Why?
Fluorescent Antibody Technique
1
1993
396
0.030
Why?
Breath Tests
1
2012
83
0.030
Why?
Gas Chromatography-Mass Spectrometry
1
2012
125
0.030
Why?
Cloning, Molecular
1
1993
524
0.030
Why?
Iceland
1
2011
6
0.020
Why?
Tumor Suppressor p53-Binding Protein 1
1
2011
12
0.020
Why?
Respiratory Tract Diseases
1
1992
140
0.020
Why?
Spain
1
2011
33
0.020
Why?
Netherlands
1
2011
65
0.020
Why?
Rats, Sprague-Dawley
1
1996
2212
0.020
Why?
Cattle
1
1993
924
0.020
Why?
Administration, Oral
1
2012
730
0.020
Why?
Severity of Illness Index
1
2018
2551
0.020
Why?
Prognosis
2
2012
3334
0.020
Why?
Meta-Analysis as Topic
1
2011
161
0.020
Why?
Carrier Proteins
1
1994
696
0.020
Why?
Flow Cytometry
1
1993
1084
0.020
Why?
Receptor, IGF Type 1
1
2009
58
0.020
Why?
Area Under Curve
1
2010
275
0.020
Why?
Cystic Fibrosis
1
1998
957
0.020
Why?
International Agencies
1
2009
29
0.020
Why?
Erythrocytes
1
1994
591
0.020
Why?
Pilot Projects
1
2012
1375
0.020
Why?
Chromatography, High Pressure Liquid
1
1989
474
0.020
Why?
Mass Spectrometry
1
2010
634
0.020
Why?
Genome, Human
1
2009
351
0.020
Why?
Models, Statistical
1
2010
602
0.020
Why?
Disease Models, Animal
1
1996
3545
0.020
Why?
Amino Acids
1
1989
451
0.020
Why?
Genotype
1
2011
1780
0.020
Why?
Receptors, Vascular Endothelial Growth Factor
1
2005
103
0.020
Why?
Genomics
1
2009
641
0.010
Why?
Epoprostenol
1
2004
133
0.010
Why?
Bronchiolitis
1
2004
81
0.010
Why?
Autoantibodies
1
2010
1354
0.010
Why?
Pituitary Neoplasms
1
2004
157
0.010
Why?
Reverse Transcriptase Polymerase Chain Reaction
1
2005
928
0.010
Why?
Fruit
1
2003
127
0.010
Why?
Genetic Predisposition to Disease
1
2011
2108
0.010
Why?
Vegetables
1
2003
133
0.010
Why?
Respiratory Function Tests
1
2004
523
0.010
Why?
Adenoma
1
2004
187
0.010
Why?
Oligonucleotide Array Sequence Analysis
1
2004
744
0.010
Why?
Weight Gain
1
2004
451
0.010
Why?
Regression Analysis
1
2003
948
0.010
Why?
Single-Blind Method
1
2001
258
0.010
Why?
Platelet Endothelial Cell Adhesion Molecule-1
1
2000
57
0.010
Why?
Carcinoma
1
2001
199
0.010
Why?
RNA
1
2005
810
0.010
Why?
Retrospective Studies
1
2015
12547
0.010
Why?
Bronchoscopes
1
1998
4
0.010
Why?
Endoglin
1
1998
20
0.010
Why?
Random Allocation
1
1998
336
0.010
Why?
Reference Values
1
1998
748
0.010
Why?
Genetic Linkage
1
1998
297
0.010
Why?
Longitudinal Studies
1
2003
2389
0.010
Why?
Comorbidity
1
2001
1457
0.010
Why?
Tumor Suppressor Protein p53
1
2000
447
0.010
Why?
Diet
1
2003
1076
0.010
Why?
Linear Models
1
1998
776
0.010
Why?
Receptors, Cell Surface
1
1998
354
0.010
Why?
Young Adult
1
2011
10498
0.010
Why?
Analysis of Variance
1
1998
1229
0.010
Why?
Alleles
1
1998
792
0.010
Why?
Infant, Premature
1
1998
477
0.010
Why?
Risk Assessment
1
2004
2976
0.010
Why?
CD47 Antigen
1
1994
21
0.010
Why?
Chromatography, Affinity
1
1994
81
0.010
Why?
Endothelium, Vascular
1
2000
850
0.010
Why?
Moths
1
1994
34
0.010
Why?
Genes
1
1994
224
0.010
Why?
Electrophoresis, Polyacrylamide Gel
1
1994
317
0.010
Why?
Cytoplasm
1
1994
256
0.010
Why?
Adolescent
1
2011
17864
0.010
Why?
Chromosome Mapping
1
1994
490
0.010
Why?
Carcinoid Tumor
1
1992
25
0.010
Why?
Lymphocytes
1
1994
334
0.010
Why?
Transfection
1
1994
872
0.010
Why?
Mice, Inbred BALB C
1
1994
1153
0.010
Why?
Dyspnea
1
1992
218
0.010
Why?
Binding Sites
1
1994
1173
0.010
Why?
Fibrosis
1
1992
454
0.010
Why?
Phenotype
1
1998
2815
0.010
Why?
Aging
1
1998
1624
0.000
Why?
Infant, Newborn
1
1998
5040
0.000
Why?
Infant
1
1998
7946
0.000
Why?
Child, Preschool
1
1998
9093
0.000
Why?
Child
1
1998
18407
0.000
Why?
Miller's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description
Physical Neighbors Expand Description
_

Copyright © 2025 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)